Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation announced today it is entering into its seventh strategic ...

In this week’s “Rising High,” The Fly’s recurring series focused on cannabis and psychedelicstock news The Fly looks back on earnings, an acquisition close and a credit facility origination. “Ensuring ...

New executive appointment made ahead of pivotal study results, potential regulatory approval and subsequent commercialization of investigational COMP360 psilocybin treatment Latest of several key ...